Live feed
Filing
SC 13D/A
SC 13D/A0001104659-22-127397·Achilles Therapeutics plc
Schedule 13D ownership disclosure
ACHILLES THERAPEUTICS PLC
Security class unavailable · CUSIP: 00449L102
Event date: 2022-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,107,508
- Percent of class
- 10.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-127397
- Form type
- SC 13D/A
- Filer
- Achilles Therapeutics plc
- CIK
- CIK 1830749
- Filed
- Dec 15, 2022
- Reporting period
- Dec 13, 2022
- Description
- Schedule 13D beneficial ownership